Copyright
©The Author(s) 2022.
World J Psychiatry. Apr 19, 2022; 12(4): 588-602
Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.588
Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.588
Table 1 Classification of classical monoaminergic antidepressants according to action mechanism and historical perspective on their clinical introduction
Family | Mechanisms of action | Acronym | Prototype substance | Period |
Tricyclic antidepressants | 5-HT and NA reuptake inhibitors with blocking action of diverse receptors | TCA | Imipramine | 1957-1980 |
Monoamine oxidase inhibitors | Irreversible MAO inhibitors | MAOI | Phenelzine | 1958-1965 |
Heterocyclic or “second generation” antidepressants | NA reuptake inhibitors with blocking action of diverse receptors | Maprotiline | 1967-1980 | |
Antagonists of α2 auto-receptors | Mianserin | 1970-1980 | ||
DA and NA reuptake inhibitors | Nomifensine | 1970-1980 | ||
5-HT reuptake inhibitor and antagonist of 5-HT2 receptors | Trazodone | 1970-1980 |
- Citation: López-Muñoz F, D’Ocón P, Romero A, Guerra JA, Álamo C. Role of serendipity in the discovery of classical antidepressant drugs: Applying operational criteria and patterns of discovery. World J Psychiatry 2022; 12(4): 588-602
- URL: https://www.wjgnet.com/2220-3206/full/v12/i4/588.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i4.588